Meeting plenary session to feature 12-Month data from MIRROR randomized controlled trial of KRYSTEXXA (pegloticase) injection with methotrexate - Horizon Therapeutics plc (Nasdaq: HZNP) today announced
Previously some of the trial's results were published in two peer-reviewed abstracts and a poster at the ASCO conference in June 2022 with additional results expected to be published in scientific journals and presented in scientific forums in the future.
Children with Chronic Graft Versus Host Disease (cGVHD) May Now Be Prescribed IMBRUVICA® (ibrutinib) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
The U.S. Food and Drug Administration approved the use of IMBRUVICA for the treatment of pediatric patients one year and older with cGVHD after failure of one.
U S Route 20 Sees Safety Upgrades Between Corvallis, Albany corvallisadvocate.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from corvallisadvocate.com Daily Mail and Mail on Sunday newspapers.